|
1
|
Boulet SL, Alexander GR, Salihu HM and
Pass M: Macrosomic births in the united states: Determinants,
outcomes, and proposed grades of risk. Am J Obstet Gynecol.
188:1372–1378. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Henriksen T: The macrosomic fetus: A
challenge in current obstetrics. Acta Obstet Gynecol Scand.
87:134–145. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang X, Decker A, Platt RW and Kramer MS:
How big is too big? The perinatal consequences of fetal macrosomia.
Am J Obstet Gynecol. 198. pp. 517 e1–6. 2008, View Article : Google Scholar
|
|
4
|
Alsammani MA and Ahmed SR: Fetal and
maternal outcomes in pregnancies complicated with fetal macrosomia.
N Am J Med Sci. 4:283–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stotland NE, Caughey AB, Breed EM and
Escobar GJ: Risk factors and obstetric complications associated
with macrosomia. Int J Gynaecol Obstet. 87:220–226. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ahlgren M, Wohlfahrt J, Olsen LW, Sørensen
TI and Melbye M: Birth weight and risk of cancer. Cancer.
110:412–419. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boney CM, Verma A, Tucker R and Vohr BR:
Metabolic syndrome in childhood: Association with birth weight,
maternal obesity, and gestational diabetes mellitus. Pediatrics.
115:e290–e296. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harder T, Plagemann A and Harder A: Birth
weight and risk of neuroblastoma: A meta-analysis. Int J Epidemiol.
39:746–756. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ognjanovic S, Carozza SE, Chow EJ, Fox EE,
Horel S, McLaughlin CC, Mueller BA, Puumala S, Reynolds P, Von
Behren J and Spector L: Birth characteristics and the risk of
childhood rhabdomyosarcoma based on histological subtype. Br J
Cancer. 102:227–231. 2010. View Article : Google Scholar :
|
|
10
|
Yu DM, Zhai FY, Zhao LY, Liu AD, Yu WT,
Jia FM, Zhang JG and Li J: Incidence of fetal macrosomia and
influencing factors in China in 2006. Chin J Child Health Care.
16:11–13. 2008.
|
|
11
|
Li G, Kong L, Li Z, Zhang L, Fan L, Zou L,
Chen Y, Ruan Y, Wang X and Zhang W: Prevalence of macrosomia and
its risk factors in china: A multicentre survey based on birth data
involving 101,723 singleton term infants. Paediatr Perinat
Epidemiol. 28:345–350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Desgagné V, Hivert MF, St-Pierre J, Guay
SP, Baillargeon JP, Perron P, Gaudet D, Brisson D and Bouchard L:
Epigenetic dysregulation of the IGF system in placenta of newborns
exposed to maternal impaired glucose tolerance. Epigenomics.
6:193–207. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Prickett AR and Oakey RJ: A survey of
tissue-specific genomic imprinting in mammals. Mol Genet Genomics.
287:621–630. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu X, Yang X, Liu Z, Wu K, Liu Z, Lin C,
Wang Y and Yan H: Placental leptin gene methylation and macrosomia
during normal pregnancy. Mol Med Rep. 9:1013–1018. 2014.PubMed/NCBI
|
|
15
|
Arora S, Rana R, Chhabra A, Jaiswal A and
Rani V: miRNA-transcription factor interactions: A combinatorial
regulation of gene expression. Mol Genet Genomics. 288:77–87. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Amiel J, de Pontual L and Henrion-Caude A:
miRNA, development and disease. Adv Genet. 80:1–36. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang D, Na Q, Song WW and Song GY: Altered
expression of miR-518b and miR-519a in the placenta is associated
with low fetal birth weight. Am J Perinatol. 31:729–734. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu P, Zhao Y, Liu M, Wang Y, Wang H, Li
YX, Zhu X, Yao Y, Wang H, Qiao J, et al: Variations of microRNAs in
human placentas and plasma from preeclamptic pregnancy.
Hypertension. 63:1276–1284. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maccani MA, Padbury JF and Marsit CJ:
miR-16 and miR-21 expression in the placenta is associated with
fetal growth. PLoS One. 6:e212102011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen L, Hou J, Ye L, Chen Y, Cui J, Tian
W, Li C and Liu L: MicroRNA-143 regulates adipogenesis by
modulating the MAP2K5-ERK5 signaling. Sci Rep.
4:38192014.PubMed/NCBI
|
|
22
|
Institute of Medicine: Nutrition During
Pregnancy. National Academies Press; Washington D.C.: 1990
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Hsu SD, Tseng YT, Shrestha S, Lin YL,
Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM, Ho SY, et al:
miRTarBase update 2014: An information resource for experimentally
validated miRNA-target interactions. Nucleic Acids Res. 42:D78–D85.
2014. View Article : Google Scholar :
|
|
25
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar
|
|
26
|
Hogg K, Price EM, Hanna CW and Robinson
WP: Prenatal and perinatal environmental influences on the human
fetal and placental epigenome. Clin Pharmacol Ther. 92:716–726.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mori Y, Ishiguro H, Kuwabara Y, Kimura M,
Mitsui A, Ogawa R, Katada T, Harata K, Tanaka T, Shiozaki M and
Fujii Y: MicroRNA-21 induces cell proliferation and invasion in
esophageal squamous cell carcinoma. Mol Med Rep. 2:235–239.
2009.PubMed/NCBI
|
|
29
|
Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY:
miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007.
View Article : Google Scholar
|
|
30
|
Quintavalle C, Donnarumma E, Iaboni M,
Roscigno G, Garofalo M, Romano G, Fiore D, De Marinis P, Croce CM
and Condorelli G: Effect of miR-21 and miR-30b/c on TRAIL-induced
apoptosis in glioma cells. Oncogene. 32:4001–4008. 2013. View Article : Google Scholar
|
|
31
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar
|
|
32
|
Ferretti C, Bruni L, Dangles-Marie V,
Pecking AP and Bellet D: Molecular circuits shared by placental and
cancer cells, and their implications in the proliferative, invasive
and migratory capacities of trophoblasts. Hum Reprod Update.
13:121–141. 2007. View Article : Google Scholar
|
|
33
|
Perry JK, Lins RJ, Lobie PE and Mitchell
MD: Regulation of invasive growth: Similar epigenetic mechanisms
underpin tumour progression and implantation in human pregnancy.
Clin Sci (Lond). 118:451–457. 2010. View Article : Google Scholar
|
|
34
|
Jiang H, Wu W, Zhang M, Li J, Peng Y, Miao
TT, Zhu H and Xu G: Aberrant upregulation of miR-21 in placental
tissues of macrosomia. J Perinatol. 34:658–663. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Seeger T, Fischer A, Muhly-Reinholz M,
Zeiher AM and Dimmeler S: Long-term inhibition of miR-21 leads to
reduction of obesity in db/db mice. Obesity (Silver Spring).
22:2352–2360. 2014. View Article : Google Scholar
|
|
36
|
Keller P, Gburcik V, Petrovic N, Gallagher
IJ, Nedergaard J, Cannon B and Timmons JA: Gene-chip studies of
adipogenesis-regulated microRNAs in mouse primary adipocytes and
human obesity. BMC Endocr Disord. 11:72011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim YJ, Hwang SH, Cho HH, Shin KK, Bae YC
and Jung JS: MicroRNA 21 regulates the proliferation of human
adipose tissue-derived mesenchymal stem cells and high-fat
diet-induced obesity alters microRNA 21 expression in white adipose
tissues. J Cell Physiol. 227:183–193. 2012. View Article : Google Scholar
|
|
38
|
Kim YJ, Hwang SJ, Bae YC and Jung JS:
MiR-21 regulates adipogenic differentiation through the modulation
of TGF-beta signaling in mesenchymal stem cells derived from human
adipose tissue. Stem Cells. 27:3093–3102. 2009.PubMed/NCBI
|
|
39
|
Esau C, Kang X, Peralta E, Hanson E,
Marcusson EG, Ravichandran LV, Sun Y, Koo S, Perera RJ, Jain R, et
al: MicroRNA-143 regulates adipocyte differentiation. J Biol Chem.
279:52361–52365. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Larqué E, Ruiz-Palacios M and Koletzko B:
Placental regulation of fetal nutrient supply. Curr Opin Clin Nutr
Metab Care. 16:292–297. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li R, Zhang L, Jia L, Duan Y, Li Y, Wang
J, Bao L and Sha N: MicroRNA-143 targets Syndecan-1 to repress cell
growth in melanoma. PLoS One. 9:e948552014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu XL, Cheng B, Li PY, Huang HJ, Zhao Q,
Dan ZL, Tian DA and Zhang P: MicroRNA-143 suppresses gastric cancer
cell growth and induces apoptosis by targeting COX-2. World J
Gastroenterol. 19:7758–7765. 2013. View Article : Google Scholar
|
|
43
|
Hanna N, Bonifacio L, Reddy P, Hanna I,
Weinberger B, Murphy S, Laskin D and Sharma D: IFN-gamma-mediated
inhibition of COX-2 expression in the placenta from term and
preterm labor pregnancies. Am J Reprod Immunol. 51:311–318. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Szabo S, Xu Y, Romero R, Fule T, Karaszi
K, Bhatti G, Varkonyi T, Varkonyi I, Krenacs T, Dong Z, et al:
Changes of placental syndecan-1 expression in preeclampsia and
HELLP syndrome. Virchows Archiv. 463:445–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ge Q, Zhu Y, Li H, Tian F, Xie X and Bai
Y: Differential expression of circulating miRNAs in maternal plasma
in pregnancies with fetal macrosomia. Int J Mol Med. 35:81–91.
2015.
|
|
46
|
Kulda V, Pesta M, Topolcan O, Liska V,
Treska V, Sutnar A, Rupert K, Ludvikova M, Babuska V, Holubec L Jr
and Cerny R: Relevance of miR-21 and miR-143 expression in tissue
samples of colorectal carcinoma and its liver metastases. Cancer
Genet Cytogenet. 200:154–160. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Borralho PM, Simões AE, Gomes SE, Lima RT,
Carvalho T, Ferreira DM, Vasconcelos MH, Castro RE and Rodrigues
CM: miR-143 overexpression impairs growth of human colon carcinoma
xenografts in mice with induction of apoptosis and inhibition of
proliferation. PLoS One. 6:e237872011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu F, Zheng S, Liu T, Liu Q, Liang M, Li
X, Sheyhidin I, Lu X and Liu W: MicroRNA-21 promotes the
proliferation and inhibits apoptosis in Eca109 via activating
ERK1/2/MAPK pathway. Mol Cell Biochem. 381:115–125. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang Y, Fan H, Zhao G, Liu D, Du L, Wang
Z, Hu Y and Hou Y: miR-16 inhibits the proliferation and
angiogenesis-regulating potential of mesenchymal stem cells in
severe pre-eclampsia. FEBS J. 279:4510–4524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zuo W, Wang ZZ and Xue J: Artesunate
induces apoptosis of bladder cancer cells by miR-16 regulation of
COX-2 expression. Int J Mol Sci. 15:14298–14312. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Koyanagi A, Zhang J, Dagvadorj A, Hirayama
F, Shibuya K, Souza JP and Gülmezoglu AM: Macrosomia in 23
developing countries: An analysis of a multicountry,
facility-based, cross-sectional survey. Lancet. 381:476–483. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mittwoch U: Blastocysts prepare for the
race to be male. Human Reprod. 8:1550–1555. 1993.
|
